Page last updated: 2024-11-07

duroquinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

durohydroquinone : A member of the class of hydroquinones that is benzene-1,4-diol carrying four methyl groups at positions 2, 3, 5 and 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID136346
CHEMBL ID160233
CHEBI ID189006
SCHEMBL ID69786
MeSH IDM0066382

Synonyms (44)

Synonym
r713g18tvf ,
unii-r713g18tvf
nsc 401619
durohydroquinone
527-18-4
2,5,6-tetramethylhydroquinone
dihydroxydurene
tetramethylhydroquinone
hydroquinone, tetramethyl-
nsc401619
duro-p-hydroquinone
nsc-401619
dqn ,
inchi=1/c10h14o2/c1-5-6(2)10(12)8(4)7(3)9(5)11/h11-12h,1-4h
duroquinol
CHEMBL160233
1,4-dihydroxy-2,3,5,6-tetramethylbenzene
2,3,5,6-tetramethyl-1,4-benzenediol
T0822
tetramethyl-1,4-benzoquinol
tetramethyl-p-hydroquinone
CHEBI:189006
2,3,5,6-tetramethylbenzene-1,4-diol
2,3,5,6-tetramethyl-1,4-dihydroquinone
tetramethyl-p-benzoquinol
tetramethylbenzene-1,4-diol
2,3,5,6-tetramethylhydroquinone
FT-0632298
SCHEMBL69786
AKOS022504988
durohydroquinone [mi]
1,4-benzenediol, 2,3,5,6-tetramethyl-
2,3,5,6-tetramethyl-1,4-benzenediol #
DTXSID60200660
mfcd00045781
2,3,5,6-tetramethylbenzoquinol
2,3,5,6-tetramethyl-p-benzoquinol
tetramethylquinol
tetramethylhydroquinone, >/=95%
tetramethyl-p-quinol
CS-0207010
Q27287869
T72569
AS-56753
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
hydroquinonesBenzenediols that have the hydroxy substituents in the 1- and 4-positions.
methylbenzeneAny alkylbenzene that is benzene substituted with one or more methyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID201729Tested for inhibition of growth of sarcoma 180 cells in culture1980Journal of medicinal chemistry, Jun, Volume: 23, Issue:6
Synthesis and antineoplastic activity of hydroquinone dialdehydes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (38.78)18.7374
1990's14 (28.57)18.2507
2000's10 (20.41)29.6817
2010's3 (6.12)24.3611
2020's3 (6.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]